Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">CEUS combined with MRI</td><td class="align_center">4 ng/mL &lt; PSA ≤ 10 ng/mL</td><td class="align_center">10 ng/mL &lt; PSA ≤ 20 ng/mL</td><td class="align_center">PSA &gt; 20 ng/mL</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Sensitivity</td><td class="align_center">100% (2/2)</td><td class="align_center">81.8% (9/11)</td><td class="align_center">100% (20/20)</td></tr><tr><td class="align_left">Specificity</td><td class="align_center">78.3% (18/23)</td><td class="align_center">60.0% (6/10)</td><td class="align_center">66.7% (4/6)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of diagnostic efficiency of CEUS combined with MRI among different levels of PSA.</div>

Evidence-Based Complementary and Alternative Medicine

tab4

Table 4

Table 4: Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer 